The Variations' in Genes Encoding TIM-3 and Its Ligand, Galectin-9, Influence on ccRCC Risk and Prognosis

被引:4
作者
Andrzejczak, Anna [1 ]
Tupikowski, Krzysztof [2 ]
Tomkiewicz, Anna [1 ]
Malkiewicz, Bartosz [3 ]
Ptaszkowski, Kuba [4 ]
Domin, Aleksandra [1 ]
Szydelko, Tomasz [3 ]
Karabon, Lidia [1 ]
机构
[1] Polish Acad Sci, Hirszfeld Inst Immunol & Expt Therapy, Dept Expt Therapy, Lab Genet & Epigenet Human Dis, PL-53114 Wroclaw, Poland
[2] Lower Silesian Ctr Oncol Pulmonol & Hematol, Subdiv Urol, PL-53413 Wroclaw, Poland
[3] Wroclaw Med Univ, Univ Ctr Excellence Urol, Dept Minimally Invas & Robot Urol, PL-50556 Wroclaw, Poland
[4] Wroclaw Med Univ, Dept Clin Biomech & Physiotherapy Motor Syst Disor, PL-50556 Wroclaw, Poland
关键词
TIM-3; HAVCR2; galectin-9 (LGALS9); clear cell renal cell carcinoma (ccRCC); single-nucleotide gene polymorphism (SNP); immunological checkpoint; disease risk; overall survival; T-CELL IMMUNOGLOBULIN; EXPRESSION; POLYMORPHISMS; SUSCEPTIBILITY; DISEASE; CANCER; DISEQUILIBRIUM; ASSOCIATION; VARIANTS; SURVIVAL;
D O I
10.3390/ijms24032042
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Renal cell cancer is the most common type of kidney cancer in adults, and clear cell renal cell carcinoma (ccRCC) is the most diagnosed type. T cell immunoglobulin and mucin-domain-containing-3 (TIM-3) belongs to immunological checkpoints that are key regulators of the immune response. One of the known TIM-3 ligands is galectin-9 (LGALS9). A limited number of studies have shown an association between TIM-3 polymorphisms and cancer risk in the Asian population; however, there is no study on the role of LGALS9 polymorphisms in cancer. The present study aimed to analyze the influence of TIM-3 and LGALS9 polymorphisms on susceptibility to ccRCC and patient overall survival (OS), with over ten years of observations. Using TaqMan probes, ARMS-PCR, and RFPL-PCR, we genotyped two TIM-3 single-nucleotide polymorphisms (SNPs): rs1036199 and rs10057302, and four LGALS9 SNPs: rs361497, rs3751093, rs4239242, and rs4794976. We found that the presence of the rs10057302 A allele (AC + AA genotypes) as well as the rs4794976 T allele (GT + TT genotypes) decreased susceptibility to ccRCC by two-fold compared to corresponding homozygotes. A subgroup analysis showed the association of some SNPs with clinical features. Moreover, TIM-3 rs1036199 significantly influenced OS. Our results indicate that variations within TIM-3 and LGALS9 genes are associated with ccRCC risk and OS.
引用
收藏
页数:18
相关论文
共 47 条
  • [31] Feto-maternal immune regulation by TIM-3/galectin-9 pathway and PD-1 molecule in mice at day 14.5 of pregnancy
    Meggyes, Matyas
    Lajko, Adrienn
    Palkovics, Tamas
    Totsimon, Anett
    Illes, Zsolt
    Szereday, Laszlo
    Miko, Eva
    PLACENTA, 2015, 36 (10) : 1153 - 1160
  • [32] Galectin-9 binding to Tim-3 renders activated human CD4+ T cells less susceptible to HIV-1 infection
    Elahi, Shokrollah
    Niki, Toshiro
    Hirashima, Mitsuomi
    Horton, Helen
    BLOOD, 2012, 119 (18) : 4192 - 4204
  • [33] Galectin-9 Controls CD40 Signaling through a Tim-3 Independent Mechanism and Redirects the Cytokine Profile of Pathogenic T Cells in Autoimmunity
    Vaitaitis, Gisela M.
    Wagner, David H., Jr.
    PLOS ONE, 2012, 7 (06):
  • [34] Stable form of galectin-9, a Tim-3 ligand, inhibits contact hypersensitivity and psoriatic reactions: A potent therapeutic tool for Th1-and/or Th17-mediated skin inflammation
    Niwa, Haruna
    Satoh, Takahiro
    Matsushima, Yuki
    Hosoya, Kazuki
    Saeki, Kazumi
    Niki, Toshiro
    Hirashima, Mitsuomi
    Yokozeki, Hiroo
    CLINICAL IMMUNOLOGY, 2009, 132 (02) : 184 - 194
  • [35] Lipopolysaccharide mediates time-dependent macrophage M1/M2 polarization through the Tim-3/Galectin-9 signalling pathway
    Zhang, Wang
    Zhang, Yuntao
    He, Yuxian
    Wang, Xiying
    Fang, Qiang
    EXPERIMENTAL CELL RESEARCH, 2019, 376 (02) : 124 - 132
  • [36] Interaction between Galectin-9/TIM-3 pathway and follicular helper CD4+ T cells contributes to viral persistence in chronic hepatitis C
    Zhuo, Ya
    Zhang, Yi-Fu
    Wu, Hong-Jie
    Qin, Lei
    Wang, Yan-Ping
    Liu, A-Min
    Wang, Xin-Hong
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 94 : 386 - 393
  • [37] Galectin-9 Signaling through TIM-3 Is Involved in Neutrophil-Mediated Gram-Negative Bacterial Killing: An Effect Abrogated within the Cystic Fibrosis Lung
    Vega-Carrascal, Isabel
    Bergin, David A.
    McElvaney, Oliver J.
    McCarthy, Cormac
    Banville, Nessa
    Pohl, Kerstin
    Hirashima, Mitsuomi
    Kuchroo, Vijay K.
    Reeves, Emer P.
    McElvaney, Noel G.
    JOURNAL OF IMMUNOLOGY, 2014, 192 (05) : 2418 - 2431
  • [38] Tim-3/Galectin-9 Pathway: Regulation of Th1 Immunity through Promotion of CD11b+Ly-6G+ Myeloid Cells
    Dardalhon, Valerie
    Anderson, Ana C.
    Karman, Jozsef
    Apetoh, Lionel
    Chandwaskar, Rucha
    Lee, David H.
    Cornejo, Melanie
    Nishi, Nozomu
    Yamauchi, Akira
    Quintana, Francisco J.
    Sobel, Raymond A.
    Hirashima, Mitsuomi
    Kuchroo, Vijay K.
    JOURNAL OF IMMUNOLOGY, 2010, 185 (03) : 1383 - 1392
  • [39] The role of T-cell immunoglobulin mucin-3 and its ligand galectin-9 in antitumor immunity and cancer immunotherapy
    Riyao Yang
    Mien-Chie Hung
    Science China Life Sciences, 2017, 60 : 1058 - 1064
  • [40] The role of T-cell immunoglobulin mucin-3 and its ligand galectin-9 in antitumor immunity and cancer immunotherapy
    Yang, Riyao
    Hung, Mien-Chie
    SCIENCE CHINA-LIFE SCIENCES, 2017, 60 (10) : 1058 - 1064